In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...
A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $72.31, marking a -2.24% move from the previous day.
Some conservation groups are calling for an effective ban on genetic modification, but others say these technologies are crucial for preserving biodiversity ...
AZ Animals on MSN
Synthetic Biology May Be the Future of Wildlife Conservation
From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...
A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...
Our experiences leave traces in the brain, stored in small groups of cells called engrams. Engrams are thought to hold the ...
Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback